Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuyuki Okada

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Carcinogenesis|February 24, 2021
LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinomaYasuyuki Okada, Naoki Takahashi, Tetsuji Takayama, et al.
Digestion|January 25, 2014
Biomarkers for predicting the efficacy of anti-epidermal growth factor receptor antibody in the treatment of colorectal cancerYasuyuki Okada, Hiroshi Miyamoto, Takahiro Goji, et al.
Seminars in Cancer Biology|October 13, 2020
Non-coding RNA biomarkers in pancreatic ductal adenocarcinomaGeeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Seminars in Cancer Biology|January 25, 2022
Corrigendum to "Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma" [Semin. Cancer Biol. 75 (2021) 153-168]Geeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Endoscopy|March 4, 2015
Epidermoid metaplasia of the esophagus with an unusual appearance on magnificationShinji Kitamura, Yasuyuki Okada, Naoki Muguruma, et al.
British Journal of Cancer|November 2, 2022
Genome-wide methylation profiling identifies a novel gene signature for patients with synchronous colorectal cancerYasuyuki Okada, Fuduan Peng, José Perea, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinomaYasuyuki Okada, Satoshi Nishiwada, Kensuke Yamamura, et al.
Gastrointestinal Endoscopy|October 17, 2013
Endoscopic submucosal dissection through a gastrostomy for early gastric cancer in patients with pharyngeal stenosisShinji Kitamura, Naoki Muguruma, Koichi Okamoto, et al.
Internal Medicine (Tokyo, Japan)|August 5, 2014
A pedunculated submucosal lesion in the stomach with inverted downgrowthYoshihiko Miyamoto, Naoki Muguruma, Seisuke Okamura, et al.
Clinical Journal of Gastroenterology|January 22, 2015
Insulin-like growth factor II-producing metastatic colon cancer with recurrent hypoglycemiaSatoshi Teramae, Hiroshi Miyamoto, Naoki Muguruma, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Carcinogenesis|February 24, 2021
LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinomaYasuyuki Okada, Naoki Takahashi, Tetsuji Takayama, et al.
Digestion|January 25, 2014
Biomarkers for predicting the efficacy of anti-epidermal growth factor receptor antibody in the treatment of colorectal cancerYasuyuki Okada, Hiroshi Miyamoto, Takahiro Goji, et al.
Seminars in Cancer Biology|October 13, 2020
Non-coding RNA biomarkers in pancreatic ductal adenocarcinomaGeeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Seminars in Cancer Biology|January 25, 2022
Corrigendum to "Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma" [Semin. Cancer Biol. 75 (2021) 153-168]Geeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Endoscopy|March 4, 2015
Epidermoid metaplasia of the esophagus with an unusual appearance on magnificationShinji Kitamura, Yasuyuki Okada, Naoki Muguruma, et al.
British Journal of Cancer|November 2, 2022
Genome-wide methylation profiling identifies a novel gene signature for patients with synchronous colorectal cancerYasuyuki Okada, Fuduan Peng, José Perea, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinomaYasuyuki Okada, Satoshi Nishiwada, Kensuke Yamamura, et al.
Gastrointestinal Endoscopy|October 17, 2013
Endoscopic submucosal dissection through a gastrostomy for early gastric cancer in patients with pharyngeal stenosisShinji Kitamura, Naoki Muguruma, Koichi Okamoto, et al.
Internal Medicine (Tokyo, Japan)|August 5, 2014
A pedunculated submucosal lesion in the stomach with inverted downgrowthYoshihiko Miyamoto, Naoki Muguruma, Seisuke Okamura, et al.
Clinical Journal of Gastroenterology|January 22, 2015
Insulin-like growth factor II-producing metastatic colon cancer with recurrent hypoglycemiaSatoshi Teramae, Hiroshi Miyamoto, Naoki Muguruma, et al.
Pageof 4